Guernsey firms Carey Olsen and Ipes have assisted Endeavour Vision on the fundraising of Endeavour Medtech Growth, which closed at its hard cap of €250 million, having been oversubscribed.
This makes it the largest dedicated medtech fund in Europe and one of the largest pure medtech funds worldwide.
Advised by healthcare and technology investor Endeavour Vision, the specialist fund is targeting European and US companies in the medical device and digital health sectors with products that have gained regulatory approval and are already generating commercial traction.
The Carey Olsen team was led by partner David Crosland and included senior associates Jan Johannsson and Gemma Campbell; the Ipes team was led by Andrew Whittaker and James Nicolle.